论文部分内容阅读
目的:对多潘立酮联合用药治疗胆汁反流性胃炎疗效进行分析探讨。方法:随机抽取2012年6月~2014年6月本院接诊的110例胆汁反流性胃炎患者作为研究对象,将其随机分为观察组和对照组,每组各55例,对照组予以多潘立酮联合硫糖铝治疗,对观察组患者予以多潘立酮联合铝碳酸镁治疗,观察并比较两组患者胃镜征象、临床表现、HP检测等临床治疗效果。结果:观察组患者的临床表现、胃镜征象、病理活检总有效率均高于对照组,不良反应的发生率低于对比组,组间比较差异具有统计学意义(P均<0.05);观察组患者HP检测好转率高于对比组,差异无统计学意义(P>0.05)。结论:多潘立酮联合铝碳酸镁治疗胆汁反流性胃炎疗效确切,具有临床推广价值。
Objective: To analyze the effect of domperidone and bile regurgitant gastritis in combination therapy. Methods: A total of 110 patients with bile reflux gastritis treated in our hospital from June 2012 to June 2014 were randomly selected as study subjects, which were randomly divided into observation group and control group, with 55 cases in each group. The control group was given Domperidone and sucralfate were given to patients in the observation group. Patients in the observation group were treated with domperidone combined with magnesium aluminum carbonate. Gastroscopy signs, clinical manifestations and HP tests were observed and compared between two groups. Results: The clinical manifestations, gastroscopy signs and the total effective rate of pathological biopsy in the observation group were higher than those in the control group, the incidence of adverse reactions was lower than that in the control group, the difference was statistically significant (P <0.05) Patients HP detection rate was higher than the control group, the difference was not statistically significant (P> 0.05). Conclusion: Domperidone combined with magnesium aluminum carbonate in the treatment of bile reflux gastritis is effective and has clinical popularization value.